New search | Conferencedetail
Print view
 
 

Antigen- Specific Immune Tolerance Drug Development Summit

evvnt Platform / evvnt
-
24.04.2018 - 26.04.2018  The Aloft Boston Seaport, 401-403 D St, 02210 Boston, USA
Time: 8:00 am to 5:00 pm
 
Conference themes
As the first generation of antigen-specific immune tolerance therapies enter clinics and with excitement around recent partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to be able to meet and share knowledge.
Professional congress organizer (PCO)
Hanson Wade
 

Enquiries and Registration:

https://go.evvnt.com/187943-2?pid=4832
Mr. Jamie Hill
1 0617 455 4188
 
Categories
Health Services
Languages
English
Congress fees
USD 3.797,00
(USD 2199 - USD 3797)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
Tel: +44 0207 3230 450
hello@evvnt.com
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationHilfswerk AustriaEuropean Health Forum GasteinÄrzte der WeltnewTreeCenter of ExcellenceÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario

Facebook

Give us your professional opinion

Start survey

Start survey